Practical Geriatrics ›› 2023, Vol. 37 ›› Issue (3): 234-237.doi: 10.3969/j.issn.1003-9198.2023.03.006
Previous Articles Next Articles
Received:2023-01-10
Online:2023-03-20
Published:2023-03-13
CLC Number:
| [1] GALLAGHER D, KISS A, LANCTOT K L, et al. Toward prevention of mild cognitive impairment in older adults with depression[J]. J Clin Psychiatry, 2018, 80(1):18m12331. [2] MUHAMMAD T, MEHER T. Association of late-life depression with cognitive impairment: evidence from a cross-sectional study among older adults in India[J]. BMC Geriatr, 2021, 21(1):364. [3] RIDDLE M, POTTER G G, MCQUOID D R, et al. Longitudinal cognitive outcomes of clinical phenotypes of late-life depression[J]. Am J Geriatr Psychiatry, 2017, 25(10):1123-1134. [4] SONG D, LI P W C, YU D S F. The association between depression and mild cognitive impairment: a cross-sectional study[J]. Int J Geriatr Psych, 2017, 33(4):672-674. [5] MIRZA S S, IKRAM M A, BOS D, et al. Mild cognitive impairment and risk of depression and anxiety: a population-based study[J]. Alzheimers Dement, 2017, 13(2):130-139. [6] ROCK P L, ROISER J P, RIEDEL W J, et al. Cognitive impairment in depression: a systematic review and meta-analysis[J]. Psychol Med, 2014, 44(10):2029-2040. [7] MESHOLAM-GATELY R I, GIULIANO A J, ZILLMER E A, et al. Verbal learning and memory in older adults with minor and major depression[J]. Arch Clin Neuropsych, 2012, 27(2):196-207. [8] RAJTAR A, SAŁAKOWSKI A, RAJTAR-ZEMBATY J, et al. Executive dysfunction in late-life depression[J]. Psychiatr Pol, 2017, 51(4):705-718. [9] SHIMADA H, PARK H, MAKIZAKO H, et al. Depressive symptoms and cognitive performance in older adults[J]. J Psychiatr Res, 2014, 57:149-156. [10] MACKIN R S, NELSON J C, DELUCCHI K L, et al. Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction[J]. Am J Geriatr Psychiatry, 2014, 22(12):1633-1641. [11] SHELINE Y I, BARCH D M, GARCIA K, et al. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed[J]. Biol Psychiat, 2006, 60(1):58-65. [12] HAYLEY S, HAKIM A M, ALBERT P R. Depression, dementia and immune dysregulation[J]. Brain, 2021, 144(3):746-760. [13] NIE J, FANG Y, CHEN Y, et al. Characteristics of dysregulated proinflammatory cytokines and cognitive dysfunction in late-life depression and amnestic mild cognitive impairment[J]. Front Immunol, 2022,12:803633. [14] JIN K, LU J, YU Z, et al. Linking peripheral IL-6, IL-1β and hypocretin-1 with cognitive impairment from major depression[J]. J Affect Disorders, 2020, 277:204-211. [15] POLETTI S, MAZZA M G, CALESELLA F, et al. Circulating inflammatory markers impact cognitive functions in bipolar depression[J]. J Psychiatr Res, 2021, 140:110-116. [16] SONG L, QUAN X, SU L, et al. Inflammation and behavioral symptoms in preoperational glioma patients: is depression, anxiety, and cognitive impairment related to markers of systemic inflammation?[J]. Brain Behav, 2020, 10(9):e01771. [17] BORTOLATO B, CARVALHO A F, SOCZYNSKA J K, et al. The involvement of TNF-α in cognitive dysfunction associated with major depressive disorder: an opportunity for domain specific treatments[J]. Curr Neuropharmacol, 2015,13(5):558-576. [18] DONIX M, HAUSSMANN R, HELLING F, et al. Cognitive impairment and medial temporal lobe structure in young adults with a depressive episode[J]. J Affect Disorders, 2018, 237:112-117. [19] ANNWEILER C, DURSUN E, FÉRON F, et al. Vitamin D and cognition in older adults: international consensus guidelines[J]. Geriatr Psychol Neuropsychiatr Vieil, 2016, 14(3):265-273. [20] DEGNER D. Vitamin D supplements: don’t forget depression and cognitive impairment[J]. BMJ, 2016, 355:i6711. [21] HARVEY P, FOSSATI P, POCHON J, et al. Cognitive control and brain resources in major depression: an fMRI study using the n-back task[J]. Neuroimage, 2005,26(3):860-869. [22] WANG J, LYU H, CHEN J, et al. Cortical alterations are associated with depression in subcortical vascular mild cognitive impairment revealed by surface-based morphometry[J]. J Alzheimers Dis, 2020, 78(2):673-681. [23] DUFFY S L, PARADISE M, HICKIE I B, et al. Cognitive impairment with and without depression history: an analysis of white matter microstructure[J]. J Psychiatr Neurosci, 2014,39(2):135-143. [24] DEPPING M S, SCHMITGEN M M, BACH C, et al. Abnormal cerebellar volume in patients with remitted major depression with persistent cognitive deficits[J]. Cerebellum, 2020, 19(6):762-770. [25] WANG X, HOU Z, YUAN Y, et al. Association study between plasma GDNF and cognitive function in late-onset depression[J]. J Affect Disorders, 2011, 132(3):418-421. [26] PITTS B L, WEN V, WHEALIN J M, et al. Depression and cognitive dysfunction in older U.S. military veterans: moderating effects of BDNF Val66Met polymorphism and physical exercise[J]. Am J Geriatr Psychiatry, 2020, 28(9):959-967. [27] SAGUD M, NIKOLAC PERKOVIC M, DVOJKOVIC A, et al. Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram[J]. Psychopharmacology, 2021, 238(6):1575-1584. [28] YOUN H, LEE S, HAN C, et al. Association between brain amyloid accumulation and neuropsychological characteristics in elders with depression and mild cognitive impairment[J]. Int J Geriatr Psych, 2019, 34(12):1907-1915. [29] YOUN H, HYUNG W S W, KIM J, et al. Brain amyloid accumulation possibly exacerbates concurrent mild cognitive impairment with subthreshold depression in older adults: a 1-year follow-up study[J]. J Affect Disorders, 2021, 295:93-100. [30] SMITH G S, KUWABARA H, NANDI A, et al. Molecular imaging of beta-amyloid deposition in late-life depression[J]. Neurobiol Aging, 2021, 101:85-93. [31] YAMAZAKI C, TAMAOKI T, NUNOMURA A, et al. Plasma amyloid-β and alzheimer’s disease-related changes in late-life depression[J]. J Alzheimers Dis, 2017, 58(2):349-354. [32] LUCIANO M. Apolipoprotein E and depressive symptoms[J]. Psychosom Med, 2014,76(2):98-100. [33] OBINATA M, MAESHIMA H, YOSHINARI N, et al. Apolipoprotein E4 increases the risk of depression recurrence[J]. J Affect Disorders, 2021, 295:628-631. [34] IVESON M H, TAYLOR A, HARRIS S E, et al. Apolipoprotein E e4 allele status and later-life depression in the Lothian Birth Cohort 1936[J]. Psychol Med, 2021, 52(16):1-9. [35] BURNS R A, ANDREWS S, CHERBUIN N, et al. Role of apolipoprotein E epsilon 4 (APOE*ε4) as an independent risk factor for incident depression over a 12-year period in cognitively intact adults across the lifespan[J]. BJPsych Open, 2020, 6(3):e47. |
| [1] | SUN Li, YIN Weihong, JING Jun, QIAN Xiali. Effects of intraoperative subanesthetic dose of esketamine on early postoperative cognitive dysfunction in elderly patients undergoing spinal surgery [J]. Practical Geriatrics, 2024, 38(10): 1039-1043. |
| [2] | YE Niansi, HU Hui, DENG Bei, LIU Xueting, ZHOU Shi, LI Yucan, WANG Xiaomeng. Current situation and influencing factors of oral health-related quality of life in elderly with mild cognitive impairment [J]. Practical Geriatrics, 2024, 38(7): 674-678. |
| [3] | GUO Xiao-juan, LIU Jie, WANG Jin, LU Wen-hui, GAO Ling, QU Qiu-min. Investigation and analysis of influencing factors of the medication adherence in patients with Alzheimer’s disease in Xi’an [J]. Practical Geriatrics, 2023, 37(1): 47-50. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
